Alpha Cognition Corp (ACOG) - Earnings per share increase in current year
FDA approval of an innovative Alzheimer's treatment has provided Alpha Cognition (ACOG) with a reputational triumph and the trust of physicians. The relative EPS YoY trend confirms this positive momentum, with the current value standing at -12.70. Potential orphan drug status guarantees pricing power, while the use of third-party contract manufacturing minimizes the risk of operational disruptions across North American hubs.
Analytical breakdowns and data insights for company alphacognition.com (ACOG)
- market value and analyst target forecast:
- market capitalization indicators:
- business book valuation details:
- debt burden and liquidity indicators:
Debt to Capital Ratio Alpha Cognition|ACOG - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Alpha Cognition Inc.|ACOG - Company Aggregate Debts|Debts to Net Assets Alpha Cognition Inc.|ACOG - Company Long-Term Liabilities|Amount of Current Liabilities Alpha Cognition|Interim Coverage Ratio alphacognition.com
- net income and valuation ratios data:
ACOG - Company Net Income|Expected Net Profit Alpha Cognition|ACOG - Price to Earnings Ratio|Price to Future Earnings Ratio Alpha Cognition Inc.|ACOG - PEG Multiple|EV/EBITDA Multiple Alpha Cognition Inc.|ACOG - Operating profit EBITDA|Net earnings per share for the last 12 months Alpha Cognition|ACOG - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months alphacognition.com|ACOG - Earnings growth in current year|Net earnings per one share growth forecast for next year Alpha Cognition
Fundamental valuation:ACOG - Alpha Cognition Corp
This indicator measures the year-over-year dynamics of net earnings per share, allowing for an assessment of profit generation efficiency and operating margin resilience during market downturns. The current value of -12.70 on the annual earnings per share growth vector reflects the scaling potential of Alpha Cognition (ACOG) intellectual property, where successful Alzheimer's drug trials could transform costs into global superprofits.
Key competitors
Biogen Inc (BIIB) - Earnings growth in current year|Net earnings per share growth this year NBIX|RGC: Earnings per share increase in current year|Earnings growth in current year AXSM|Net earnings per share growth this year acadia-pharm.com ACAD|Earnings per share growth in current year Xenon XENE|Viking Therapeutics Inc (VKTX) - Earnings per share growth rate in current year|Supernus Pharma - Earnings growth in current year|Net earnings per share change in current year Catalyst Corp (CPRX)|Denali Therapeutics (DNLI) - Earnings per share growth in current year|Earnings per share growth this year HRMY|BHVN (Biohaven) - Earnings growth in current year|Amylyx Pharmaceuticals Inc (AMLX) - Expected net earnings per share growth this year|Net earnings per share growth this year TRVI (Trevi Pharma)|Net earnings per one share growth for the current year PRAX|Earnings growth in current year AVXL (Anavex Life Sciences)|Expected net earnings per share growth this year ceribell.com (CBLL)|PRTA - Earnings per share growth in current year|Earnings per share growth rate in current year Alector, Inc.|Annexon Inc. (ANNX) - Earnings per share growth in current year|Earnings per share growth this year OMER|NGNE (Neurogene Inc.) - Earnings growth in current year|Earnings growth in current year acimmune.com|Earnings growth in current year VYGR|Net earnings per share growth this year Neumora NMRA|Earnings per share growth in current year Scilex Holding Co. SCLX|Tevogen Bio Inc. (TVGN) - Earnings per share growth rate in current year|Cognition Therapeutics, Inc. - Earnings growth in current year|Net earnings per share change in current year inhibikase.com (IKT)|Cassava Sciences (SAVA) - Earnings per share growth in current year|Earnings per share growth this year ASRT|COYA (Coya Therapeutics Inc) - Earnings growth in current year|Earnings per share growth rate in current year VistaGen Therapeutics Inc VTGN|Net earnings per share growth this year OVID (Ovid Therapeutics Inc.)|Earnings growth in current year acumenpharm.com (ABOS)|Earnings per share growth in current year CervoMed CRVO|Earnings per share increase in current year ATHE|CLNN - Earnings per share growth in current year|Earnings per share growth rate in current year PepGen Inc.|JUNS: Earnings growth in current year|relmada.com (RLMD) - Earnings growth in current year|Earnings per share growth in current year Annovis Bio|Earnings per share growth in current year GRCE|Earnings per share growth in current year Firefly Neuroscience Inc (AIFF)|KLTO: Earnings per share trend in current year|Earnings growth in current year NRSN (NeuroSense Therapeutics Ltd.)|Earnings per share increase in current year RVPH|MetaVia, Inc. - Earnings growth in current year|NRXS - Earnings growth in current year|HSDT (heliusmedical.com) - Net earnings per share growth this year|Passage Bio - Earnings per share increase in current year|NEUP (Neuphoria Therapeutics, Inc.) - Earnings growth in current year|Net earnings per share growth this year minervaneurosciences.com (NERV)|Earnings per share growth in current year Athira Pharma (ATHA)|ADXN - Earnings per share growth rate in current year|Earnings growth in current year ALZN (Alzamend Neuro)|Net earnings per share change in current year Cyclerion Therapeutics Inc.|PTIX - Earnings per share growth in current year|KTTA (Pasithea Therapeutics) - Earnings per share growth this year|CRGT: Earnings growth in current year|ATXI - Expected net earnings per share growth this year|Net earnings per share growth this year BCLI|CARA (Cara Therapeutics Inc) - Net earnings per one share growth for the current year|Earnings growth in current year CHRO|Expected net earnings per share growth this year eliemtx.com|Earnings per share growth in current year Intra-Cellular Therapies, Inc. ITCI|Longboard Pharmaceuticals Inc (LBPH) - Earnings per share growth rate in current year|MRNS - Earnings per share growth in current year|NKGN (NKGen Biotech Corp) - Earnings per share growth this year|NRBO: Earnings growth in current year|sagerx.com (SAGE) - Earnings growth in current year|SNPX (Synaptogenix) - Earnings growth in current year|Net earnings per share growth this year Trevena Inc. (TRVN)|Earnings per share growth in current year Vigil Neuroscience (VIGL)|WENA - Earnings per share growth rate in current year|Earnings growth in current year CERE (Cerevel Therapeutics)
